This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-CD48 monoclonal antibody, clone NFN-213 [PE]
catalog :
DCABH-1208
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
NFN-213
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-1208
Product Name :
Anti-CD48 monoclonal antibody, clone NFN-213 [PE]
Brand :
Creative Diagnostics
Abbr :
Anti-CD48 MAb, PE-Conjugated
Host animal :
Mouse
Clone :
NFN-213
Official Symbol :
CD48
Clonality :
Monoclonal
Application :
FC
Target :
CD48
Species Reactivity :
Human
Conjugate :
PE
Antibody Type :
Primary Antibodies
Immunogen :
Raji Human Burkitts lymphoma cell line.
Alternative Names :
CD48; CD48 molecule; BCM1, CD48 antigen (B cell membrane protein) , CD48 molecule; CD48 antigen; BLAST; hCD48; mCD48; SLAMF2; TCT.1; BCM1 surface antigen; leukocyte antigen MEM-102; B-lymphocyte activation marker BLAST-1; CD48 antigen (B-cell membrane p
UniProt ID :
A0A087X1S7
Antibody Isotype :
IgG1
Size :
50 Tests
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments